Article Details
Retrieved on: 2022-10-17 16:33:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Kineta struck a collaboration deal with Merck to pair its anti-VISTA monoclonal antibody with Keytruda (pembrolizumab) as a potential treatment ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here